MENU
+Compare
DERM
Stock ticker: NASDAQ
AS OF
Aug 18, 11:49 AM (EDT)
Price
$7.12
Change
+$0.17 (+2.45%)
Capitalization
169.43M

DERM Journey Medical Corp Forecast, Technical & Fundamental Analysis

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions... Show more

Industry: #Biotechnology
DERM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DERM with price predictions
Aug 15, 2025

Aroon Indicator for DERM shows an upward move is likely

DERM's Aroon Indicator triggered a bullish signal on August 08, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 138 similar instances where the Aroon Indicator showed a similar pattern. In of the 138 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DERM advanced for three days, in of 194 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DERM moved out of overbought territory on August 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DERM as a result. In of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DERM turned negative on August 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

DERM moved below its 50-day moving average on August 15, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DERM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DERM broke above its upper Bollinger Band on August 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DERM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.803) is normal, around the industry mean (16.499). P/E Ratio (39.077) is within average values for comparable stocks, (72.127). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.761). DERM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (2.707) is also within normal values, averaging (40.137).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DERM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
DERM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DERM is expected to report earnings to fall 103.12% to 0 cents per share on November 05

Journey Medical Corp DERM Stock Earnings Reports
Q3'25
Est.
$0.00
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.27
Q3'24
Beat
by $0.05
The last earnings report on August 12 showed earnings per share of -15 cents, missing the estimate of -10 cents. With 53.16K shares outstanding, the current market capitalization sits at 169.43M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9237 E Via de Ventura Boulevard
Phone
+1 480 434-6670
Employees
58
Web
https://www.journeymedicalcorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRYMF89.682.30
+2.63%
Prysmian S.P.A.
AANNF3.57N/A
N/A
Aroundtown SA
HDVTY0.03N/A
N/A
Henderson Investment Ltd.
ITPC90.00N/A
N/A
Intrepid Capital Corp.
DTLIF11.62N/A
N/A
D2L INC.

DERM and Stocks

Correlation & Price change

A.I.dvisor tells us that DERM and AQST have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DERM and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DERM
1D Price
Change %
DERM100%
-4.27%
AQST - DERM
27%
Poorly correlated
N/A
SWGHF - DERM
25%
Poorly correlated
N/A
ETON - DERM
23%
Poorly correlated
+2.04%
YCBD - DERM
22%
Poorly correlated
-10.98%
CRDL - DERM
22%
Poorly correlated
N/A
More

Groups containing DERM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DERM
1D Price
Change %
DERM100%
-4.27%
Pharmaceuticals: Generic
industry (228 stocks)
3%
Poorly correlated
-1.77%